Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease

Hypertension. 2021 Jan;77(1):28-38. doi: 10.1161/HYPERTENSIONAHA.120.16064. Epub 2020 Nov 23.

Abstract

Hypertension-mediated organ damage frequently includes renal function decline in which several mechanisms are involved. The present review outlines the state of the art on extracellular vesicles in hypertension and hypertension-related renal damage. Emerging evidence indicates that extracellular vesicles, small vesicles secreted by most cell types and body fluids, are involved in cell-to-cell communication and are key players mediating biological processes such as inflammation, endothelial dysfunction or fibrosis, mechanisms present the onset and progression of hypertension-associated kidney disease. We address the potential use of extracellular vesicles as markers of hypertension-mediated kidney damage severity and their application as therapeutic agents in hypertension-associated renal damage. The capacity of exosomes to deliver a wide variety of cargos to the target cell efficiently makes them a potential drug delivery system for treatment of renal diseases.

Keywords: exosomes; extracellular vesicles; hypertension; kidney diseases; therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers
  • Drug Delivery Systems
  • Exosomes
  • Extracellular Vesicles / physiology*
  • Humans
  • Hypertension, Renal / etiology
  • Hypertension, Renal / therapy*
  • Mesenchymal Stem Cells / ultrastructure
  • MicroRNAs / physiology
  • Nephritis / etiology
  • Nephritis / therapy*

Substances

  • Biomarkers
  • MicroRNAs

Supplementary concepts

  • Hypertensive Nephropathy